AbbVie Corporation v. Jamp Pharma Corporation
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court |
| Judge | McVeigh |
| Citation | 2023 FC 1520 |
| Docket Number | T-557-21; T-561-21; T-573-21; T-577-21 |
| Date | 04 December 2023 |
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeUnlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Start Your 7-day Trial
6 practice notes
-
Pharmascience Inc. v. Janssen Inc.
...HCA 50, 253 C.L.R. 284; Cobalt Pharmaceuticals Co. v. Bayer Inc., 2015 FCA 116, 131 C.P.R. (4th) 99; AbbVie Corp. v. JAMP Pharma Corp., 2023 FC 1520; Hoffmann-La Roche Ltd. v. Sandoz Canada Inc., 2021 FC 384, 185 C.P.R. (4th) 167; Biogen Canada Inc. v. Taro Pharmaceuticals Inc., 2020 FC 621......
-
GE Renewable Energy Canada Inc. v. Canmec Industrial Inc. et al.
...permanent injunction even if I had decided otherwise on the issue of copyright infringement: AbbVie Corporation v Jamp Pharma Corporation, 2023 FC 1520 [AbbVie] at para 642; Unilever PLC v Procter & Gamble Inc, 1993 CanLII 17527 (FCTTD), 47 CPR (3d) 479 [Unilever PLC] at (2) Should the ......
-
2023 Year In Review: Life Sciences In Canada
...studies data. Find a full summary of Allergan v Juno here. AbbVie Corporation and Abbvie Biotechnology Ltd v JAMP Pharma Corporation, 2023 FC 1520 In a lengthy decision, the Federal Court invalidated AbbVie's CA2,504,868 (868 patent) and CA2,801,917 (917 Patent) patents for obviousness, but......
-
Federal Court Clarifies Validity And Evidence-Related Legal Principles, And Declines To Grant Injunction For Infringed Patent In Humira Decision
...key points from the Federal Court's lengthy decision in AbbVie Corporation and Abbvie Biotechnology Ltd v JAMP Pharma Corporation, 2023 FC 1520 JAMP Pharma Corporation's ("JAMP")'s SIMLANDI biosimilar relates to AbbVie Corporation and Abbvie Biotechnology's ("AbbVie") HUMIRA biologic, the m......
Get Started for Free
2 cases
-
Pharmascience Inc. v. Janssen Inc.
...HCA 50, 253 C.L.R. 284; Cobalt Pharmaceuticals Co. v. Bayer Inc., 2015 FCA 116, 131 C.P.R. (4th) 99; AbbVie Corp. v. JAMP Pharma Corp., 2023 FC 1520; Hoffmann-La Roche Ltd. v. Sandoz Canada Inc., 2021 FC 384, 185 C.P.R. (4th) 167; Biogen Canada Inc. v. Taro Pharmaceuticals Inc., 2020 FC 621......
-
GE Renewable Energy Canada Inc. v. Canmec Industrial Inc. et al.
...permanent injunction even if I had decided otherwise on the issue of copyright infringement: AbbVie Corporation v Jamp Pharma Corporation, 2023 FC 1520 [AbbVie] at para 642; Unilever PLC v Procter & Gamble Inc, 1993 CanLII 17527 (FCTTD), 47 CPR (3d) 479 [Unilever PLC] at (2) Should the ......
4 firm's commentaries
-
2023 Year In Review: Life Sciences In Canada
...studies data. Find a full summary of Allergan v Juno here. AbbVie Corporation and Abbvie Biotechnology Ltd v JAMP Pharma Corporation, 2023 FC 1520 In a lengthy decision, the Federal Court invalidated AbbVie's CA2,504,868 (868 patent) and CA2,801,917 (917 Patent) patents for obviousness, but......
-
Federal Court Clarifies Validity And Evidence-Related Legal Principles, And Declines To Grant Injunction For Infringed Patent In Humira Decision
...key points from the Federal Court's lengthy decision in AbbVie Corporation and Abbvie Biotechnology Ltd v JAMP Pharma Corporation, 2023 FC 1520 JAMP Pharma Corporation's ("JAMP")'s SIMLANDI biosimilar relates to AbbVie Corporation and Abbvie Biotechnology's ("AbbVie") HUMIRA biologic, the m......
-
Federal Court Declines To Grant Injunction For Infringement Of HUMIRA Formulation Patent
...regimens and formulations of adalimumab (AbbVie's HUMIRA) and JAMP's biosimilar, SIMLANDI: AbbVie Corporation v Jamp Pharma Corporation, 2023 FC 1520. At issue were Canadian Patent 2,504,868 (868 patent): adalimumab dosing regimens for treating inflammatory bowel disease (IBD) (including Cr......
-
Canadian Patent Law In Review 2023: Notable Cases And Trends For 2024
...Label": Apotex Inc. v. Janssen Inc., 2023 FCA 220 Infringement Without an Injunction: AbbVie Corporation v. JAMP Pharma Corporation, 2023 FC 1520 PMPRB Announces Next Steps in Guidelines Consultation Process Import, Export, and Possession as Infringement: Deeproot Green Infrastructure, LLC ......